Application of Shexiang Baoxin Pill Combined with Rosuvastatin Calcium Tablets in the Treatment of Angina Pectoris due to Coronary Atherosclerotic Heart Disease
Abstract
Objective: To analyze the therapeutic efficacy of Shexiang Baoxin Pill combined with Rosuvastatin Calcium Tablets (ROS) in patients with angina pectoris due to coronary atherosclerotic heart disease (CHD-AP). Methods: Eighty CHD-AP patients admitted for treatment from January 2023 to December 2024 were selected and evenly divided using a random number table. The combined group (40 cases) received treatment with Shexiang Baoxin Pill combined with ROS, while the reference group (40 cases) received ROS monotherapy. The overall response rate, frequency and duration of AP attacks, blood lipid levels, and cardiac function indicators were compared between the two groups. Results: The combined group exhibited a higher overall response rate than the reference group. After treatment, the frequency and duration of AP attacks were lower in the combined group than in the reference group. Additionally, blood lipid levels and cardiac function indicators were superior in the combined group (p < 0.05). Conclusion: The combination of Shexiang Baoxin Pill and ROS demonstrates favorable therapeutic effects in CHD-AP patients, effectively preventing AP attacks, regulating blood lipid levels, protecting cardiac function, and reducing disease risk.
References
Wang X, Dong Z, Zhang H, et al., 2023, Pharmacoeconomic Evaluation of Shexiang Baoxin Pill, Compound Danshen Dripping Pill, and Naoxintong Capsule in the Treatment of Stable Angina Pectoris in Coronary Heart Disease. Chinese Journal of Hospital Pharmacy, 23(2): 230–233.
Xia Z, Zhang X, Jin L, et al., 2021, Clinical Efficacy of Shexiang Baoxin Pill Combined with Conventional Treatment in Patients with Stable Angina Pectoris in Coronary Heart Disease. Chinese Traditional Patent Medicine, 43(7): 1772–1774.
Li J, Zhang H, Chen L, 2021, Observation on the Efficacy and Safety of Felodipine Combined with Shexiang Baoxin Pill in the Treatment of Coronary Heart Disease Complicated with Angina Pectoris. Guizhou Medical Journal, 45(11): 1733–1734.
Wang X, Zhang H, Wang X, et al., 2021, Evidence-Based Pharmacoeconomic Evaluation of Shexiang Baoxin Pill and Compound Danshen Dripping Pill in the Treatment of Angina Pectoris in Coronary Heart Disease. Chinese Journal of Hospital Pharmacy, 21(1): 71–76.
Li Y, 2025, Efficacy of Shexiang Baoxin Pill Combined with Rosuvastatin Calcium Tablets in the Treatment of Angina Pectoris in Coronary Heart Disease and Its Effects on Hemorheology and Blood Lipids. Health Care Essence, 26(14): 81–84.
Su J, Ma Y, 2021, Efficacy Analysis of Shexiang Baoxin Pill Combined with Rosuvastatin in the Treatment of Angina Pectoris in Coronary Heart Disease. Modern Medicine and Health Research (Electronic Edition), 5(13): 38–41.
Zheng Y, Liu Y, Wang M, et al., 2021, Systematic Evaluation of the Efficacy and Safety of Shexiang Baoxin Pill in the Treatment of Angina Pectoris in Coronary Heart Disease. Chinese Journal of Hospital Pharmacy, 21(2): 199–203.
Cui W, 2025, Analysis of the Combined Application Effect of Shexiang Baoxin Pill and Rosuvastatin Calcium Tablets in the Treatment of Angina Pectoris in Coronary Heart Disease. Inner Mongolia Journal of Traditional Chinese Medicine, 44(2): 27–29.
Cheng Z, Yang Y, Cheng Y, et al., 2024, Efficacy of Shexiang Baoxin Pill Combined with Rosuvastatin Calcium Tablets in the Treatment of Angina Pectoris in Coronary Heart Disease and Its Effects on Hemorheology and Blood Lipids. Clinical Rational Drug Use, 17(11): 44–47.
Zhao Y, Xie L, 2021, Observation on the Clinical Efficacy and Safety of Shexiang Baoxin Pill Combined with Diltiazem in the Treatment of Stable Angina Pectoris in Elderly Patients with Coronary Heart Disease. Guizhou Medical Journal, 45(12): 1934–1935.
